First Time Loading...

ATAI Life Sciences NV
NASDAQ:ATAI

Watchlist Manager
ATAI Life Sciences NV Logo
ATAI Life Sciences NV
NASDAQ:ATAI
Watchlist
Price: 2.05 USD -3.76% Market Closed
Updated: May 6, 2024
Section:
 

Wall Street
Price Targets

ATAI Price Targets Summary
ATAI Life Sciences NV

Wall Street analysts forecast ATAI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ATAI is 10.9 USD with a low forecast of 5.15 USD and a high forecast of 22.05 USD.

ATAI Lowest Forecast
Wall Street Target
5.15 USD
151% Upside
ATAI Average Forecast
Wall Street Target
10.9 USD
432% Upside
ATAI Highest Forecast
Wall Street Target
22.05 USD
976% Upside
Lowest
Price Target
5.15 USD
151% Upside
Average
Price Target
10.9 USD
432% Upside
Highest
Price Target
22.05 USD
976% Upside

ATAI Last Price Targets
ATAI Life Sciences NV

The latest public price target was made on Apr 3, 2024 by Jason McCarthy from Maxim Group , who expects ATAI stock to rise by 193% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Jason McCarthy
Maxim Group
6 USD
Upside 193%
1 month ago
Apr 3, 2024
Maxim Group Upgrades atai Life Sciences N.V (ATAI) to Buy
StreetInsider
Jason McCarthy
Maxim Group
Price Target 6 USD
Upside/Downside 193%
View Source
ATAI Life Sciences NV Competitors:
Price Targets
JBCHEPHARM
J B Chemicals and Pharmaceuticals Ltd
6% Downside
CPH
Cipher Pharmaceuticals Inc
32% Upside
AJANTPHARM
Ajanta Pharma Ltd
11% Downside
D
170900
Dong-A ST Co Ltd
35% Upside
JBCHEPHARM
J B Chemicals and Pharmaceuticals Ltd
6% Downside
CPH
Cipher Pharmaceuticals Inc
32% Upside
AJANTPHARM
Ajanta Pharma Ltd
11% Downside
D
170900
Dong-A ST Co Ltd
35% Upside
2348
Dawnrays Pharmaceutical (Holdings) Ltd
133% Upside
T
TRUL
Trulieve Cannabis Corp
33% Upside
APLLTD
Alembic Pharmaceuticals Ltd
14% Downside
1789
ScinoPharm Taiwan Ltd
5% Downside

Revenue
Forecast

Revenue Estimate
ATAI Life Sciences NV

The compound annual growth rate of ATAI Life Sciences NV's revenue for the next 3 years is 432%.

N/A
Past Growth
432%
Estimated Growth
Estimates Accuracy
8%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
ATAI Life Sciences NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
ATAI Life Sciences NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

See Also

Summary
ATAI intrinsic value, competitors valuation, and company profile.
DCF Valuation
ATAI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ATAI stock valuation using valuation multiples.
Wall Street Estimates
ATAI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ATAI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ATAI's stock price target?
Price Target
10.9 USD

According to Wall Street analysts, the average 1-year price target for ATAI is 10.9 USD with a low forecast of 5.15 USD and a high forecast of 22.05 USD.

What is ATAI Life Sciences NV's Revenue forecast?
Projected CAGR
432%

The compound annual growth rate of ATAI Life Sciences NV's revenue for the next 3 years is 432%.

ALPHA SPREAD
Join more than 134,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.